IBDEI0EI ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19559,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19559,1,4,0)
 ;;=4^714.9
 ;;^UTILITY(U,$J,358.3,19559,1,5,0)
 ;;=5^Inflammatory Arthritis
 ;;^UTILITY(U,$J,358.3,19559,2)
 ;;=^272122
 ;;^UTILITY(U,$J,358.3,19560,0)
 ;;=729.1^^129^1105^11
 ;;^UTILITY(U,$J,358.3,19560,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19560,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,19560,1,5,0)
 ;;=5^Myalgia
 ;;^UTILITY(U,$J,358.3,19560,2)
 ;;=^80160
 ;;^UTILITY(U,$J,358.3,19561,0)
 ;;=725.^^129^1105^12
 ;;^UTILITY(U,$J,358.3,19561,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19561,1,4,0)
 ;;=4^725.
 ;;^UTILITY(U,$J,358.3,19561,1,5,0)
 ;;=5^Polymyalgia Rheumatica
 ;;^UTILITY(U,$J,358.3,19561,2)
 ;;=^96292
 ;;^UTILITY(U,$J,358.3,19562,0)
 ;;=796.4^^129^1105^13
 ;;^UTILITY(U,$J,358.3,19562,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19562,1,4,0)
 ;;=4^796.4
 ;;^UTILITY(U,$J,358.3,19562,1,5,0)
 ;;=5^Positive Ana
 ;;^UTILITY(U,$J,358.3,19562,2)
 ;;=^273466
 ;;^UTILITY(U,$J,358.3,19563,0)
 ;;=696.0^^129^1105^14
 ;;^UTILITY(U,$J,358.3,19563,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19563,1,4,0)
 ;;=4^696.0
 ;;^UTILITY(U,$J,358.3,19563,1,5,0)
 ;;=5^Psoriatic Arthritis
 ;;^UTILITY(U,$J,358.3,19563,2)
 ;;=^100320
 ;;^UTILITY(U,$J,358.3,19564,0)
 ;;=443.0^^129^1105^15
 ;;^UTILITY(U,$J,358.3,19564,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19564,1,4,0)
 ;;=4^443.0
 ;;^UTILITY(U,$J,358.3,19564,1,5,0)
 ;;=5^Raynaud'S Syndrome
 ;;^UTILITY(U,$J,358.3,19564,2)
 ;;=^103165
 ;;^UTILITY(U,$J,358.3,19565,0)
 ;;=714.0^^129^1105^16
 ;;^UTILITY(U,$J,358.3,19565,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19565,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,19565,1,5,0)
 ;;=5^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,19565,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,19566,0)
 ;;=726.19^^129^1105^17
 ;;^UTILITY(U,$J,358.3,19566,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19566,1,4,0)
 ;;=4^726.19
 ;;^UTILITY(U,$J,358.3,19566,1,5,0)
 ;;=5^Rotator Cuff Dis
 ;;^UTILITY(U,$J,358.3,19566,2)
 ;;=^272527
 ;;^UTILITY(U,$J,358.3,19567,0)
 ;;=447.6^^129^1105^21
 ;;^UTILITY(U,$J,358.3,19567,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19567,1,4,0)
 ;;=4^447.6
 ;;^UTILITY(U,$J,358.3,19567,1,5,0)
 ;;=5^Vasculitis
 ;;^UTILITY(U,$J,358.3,19567,2)
 ;;=^10396
 ;;^UTILITY(U,$J,358.3,19568,0)
 ;;=V70.7^^129^1105^22
 ;;^UTILITY(U,$J,358.3,19568,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19568,1,4,0)
 ;;=4^V70.7
 ;;^UTILITY(U,$J,358.3,19568,1,5,0)
 ;;=5^Exam In Clinical Trial
 ;;^UTILITY(U,$J,358.3,19568,2)
 ;;=^295597
 ;;^UTILITY(U,$J,358.3,19569,0)
 ;;=710.0^^129^1105^18
 ;;^UTILITY(U,$J,358.3,19569,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19569,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,19569,1,5,0)
 ;;=5^Syst Lupus Erythematosis (CC)
 ;;^UTILITY(U,$J,358.3,19569,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,19570,0)
 ;;=359.6^^129^1105^8
 ;;^UTILITY(U,$J,358.3,19570,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19570,1,4,0)
 ;;=4^359.6
 ;;^UTILITY(U,$J,358.3,19570,1,5,0)
 ;;=5^Infl Myopathy In Oth Dis
 ;;^UTILITY(U,$J,358.3,19570,2)
 ;;=^268543
 ;;^UTILITY(U,$J,358.3,19571,0)
 ;;=727.03^^129^1105^20
 ;;^UTILITY(U,$J,358.3,19571,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19571,1,4,0)
 ;;=4^727.03
 ;;^UTILITY(U,$J,358.3,19571,1,5,0)
 ;;=5^Trigger Finger
 ;;^UTILITY(U,$J,358.3,19571,2)
 ;;=^272560
 ;;^UTILITY(U,$J,358.3,19572,0)
 ;;=726.32^^129^1105^19
 ;;^UTILITY(U,$J,358.3,19572,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19572,1,4,0)
 ;;=4^726.32
 ;;^UTILITY(U,$J,358.3,19572,1,5,0)
 ;;=5^Tennis Elbow aka/ Lateral Epicondylitis
 ;;^UTILITY(U,$J,358.3,19572,2)
 ;;=^117801
 ;;^UTILITY(U,$J,358.3,19573,0)
 ;;=088.81^^129^1105^10
 ;;^UTILITY(U,$J,358.3,19573,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19573,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,19573,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,19573,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,19574,0)
 ;;=710.0^^129^1106^7
 ;;^UTILITY(U,$J,358.3,19574,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19574,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,19574,1,5,0)
 ;;=5^Syst Lupus Erythematosis
 ;;^UTILITY(U,$J,358.3,19574,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,19575,0)
 ;;=710.1^^129^1106^4
 ;;^UTILITY(U,$J,358.3,19575,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19575,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,19575,1,5,0)
 ;;=5^CREST Syndrome ala/Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,19575,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,19576,0)
 ;;=710.2^^129^1106^6
 ;;^UTILITY(U,$J,358.3,19576,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19576,1,4,0)
 ;;=4^710.2
 ;;^UTILITY(U,$J,358.3,19576,1,5,0)
 ;;=5^Sicca Syndrome
 ;;^UTILITY(U,$J,358.3,19576,2)
 ;;=^192145
 ;;^UTILITY(U,$J,358.3,19577,0)
 ;;=716.99^^129^1106^1
 ;;^UTILITY(U,$J,358.3,19577,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19577,1,4,0)
 ;;=4^716.99
 ;;^UTILITY(U,$J,358.3,19577,1,5,0)
 ;;=5^Arthropathy Nos-Mult
 ;;^UTILITY(U,$J,358.3,19577,2)
 ;;=^272256
 ;;^UTILITY(U,$J,358.3,19578,0)
 ;;=733.40^^129^1106^3
 ;;^UTILITY(U,$J,358.3,19578,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19578,1,4,0)
 ;;=4^733.40
 ;;^UTILITY(U,$J,358.3,19578,1,5,0)
 ;;=5^Asept Necrosis Bone Nos
 ;;^UTILITY(U,$J,358.3,19578,2)
 ;;=^276833
 ;;^UTILITY(U,$J,358.3,19579,0)
 ;;=716.90^^129^1106^2
 ;;^UTILITY(U,$J,358.3,19579,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19579,1,4,0)
 ;;=4^716.90
 ;;^UTILITY(U,$J,358.3,19579,1,5,0)
 ;;=5^Arthropathy/Arthritis/ Unsp.
 ;;^UTILITY(U,$J,358.3,19579,2)
 ;;=^66343
 ;;^UTILITY(U,$J,358.3,19580,0)
 ;;=716.90^^129^1106^5
 ;;^UTILITY(U,$J,358.3,19580,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19580,1,4,0)
 ;;=4^716.90
 ;;^UTILITY(U,$J,358.3,19580,1,5,0)
 ;;=5^Reactive Arthritis Aka/Arthropathy Nos-Unsp
 ;;^UTILITY(U,$J,358.3,19580,2)
 ;;=^66343
 ;;^UTILITY(U,$J,358.3,19581,0)
 ;;=355.6^^129^1107^2
 ;;^UTILITY(U,$J,358.3,19581,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19581,1,4,0)
 ;;=4^355.6
 ;;^UTILITY(U,$J,358.3,19581,1,5,0)
 ;;=5^Morton'S Neuroma Aka/Planter Nerve Lesion
 ;;^UTILITY(U,$J,358.3,19581,2)
 ;;=^268517
 ;;^UTILITY(U,$J,358.3,19582,0)
 ;;=370.52^^129^1107^1
 ;;^UTILITY(U,$J,358.3,19582,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19582,1,4,0)
 ;;=4^370.52
 ;;^UTILITY(U,$J,358.3,19582,1,5,0)
 ;;=5^Cogan'S Syndrome Aka/Diffuse Intestitial Keratitis
 ;;^UTILITY(U,$J,358.3,19582,2)
 ;;=^268941
 ;;^UTILITY(U,$J,358.3,19583,0)
 ;;=336.8^^129^1107^4
 ;;^UTILITY(U,$J,358.3,19583,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19583,1,4,0)
 ;;=4^336.8
 ;;^UTILITY(U,$J,358.3,19583,1,5,0)
 ;;=5^Myelopathy Nec
 ;;^UTILITY(U,$J,358.3,19583,2)
 ;;=^268431
 ;;^UTILITY(U,$J,358.3,19584,0)
 ;;=446.4^^129^1108^5
 ;;^UTILITY(U,$J,358.3,19584,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19584,1,4,0)
 ;;=4^446.4
 ;;^UTILITY(U,$J,358.3,19584,1,5,0)
 ;;=5^Wegener'S Granulomatosis
 ;;^UTILITY(U,$J,358.3,19584,2)
 ;;=^127623
 ;;^UTILITY(U,$J,358.3,19585,0)
 ;;=446.0^^129^1108^1
 ;;^UTILITY(U,$J,358.3,19585,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19585,1,4,0)
 ;;=4^446.0
 ;;^UTILITY(U,$J,358.3,19585,1,5,0)
 ;;=5^Polyarteritis Nodosa
 ;;^UTILITY(U,$J,358.3,19585,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,19586,0)
 ;;=446.7^^129^1108^3
 ;;^UTILITY(U,$J,358.3,19586,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19586,1,4,0)
 ;;=4^446.7
 ;;^UTILITY(U,$J,358.3,19586,1,5,0)
 ;;=5^Takayasu'S Disease
 ;;^UTILITY(U,$J,358.3,19586,2)
 ;;=^117141
 ;;^UTILITY(U,$J,358.3,19587,0)
 ;;=1.5^1^129^1108^2^       CC   Code also Complications or Cormorbidity^1^0
 ;;^UTILITY(U,$J,358.3,19587,1,0)
 ;;=^358.31IA^0^0
 ;;^UTILITY(U,$J,358.3,19588,0)
 ;;=7.5^1^129^1108^6^       CC   Code also Complications or Comorbidity^^0
 ;;^UTILITY(U,$J,358.3,19588,1,0)
 ;;=^358.31IA^0^0
 ;;^UTILITY(U,$J,358.3,19589,0)
 ;;=6^1^129^1108^4^       CC   Code also Complications or Comorbidity^0^0
 ;;^UTILITY(U,$J,358.3,19589,1,0)
 ;;=^358.31IA^0^0
 ;;^UTILITY(U,$J,358.3,19590,0)
 ;;=790.09^^129^1109^1
 ;;^UTILITY(U,$J,358.3,19590,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19590,1,4,0)
 ;;=4^790.09
 ;;^UTILITY(U,$J,358.3,19590,1,5,0)
 ;;=5^Abnormal Red Blood Cells
 ;;^UTILITY(U,$J,358.3,19590,2)
 ;;=^322022
 ;;^UTILITY(U,$J,358.3,19591,0)
 ;;=285.9^^129^1109^2
 ;;^UTILITY(U,$J,358.3,19591,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19591,1,4,0)
 ;;=4^285.9
 ;;^UTILITY(U,$J,358.3,19591,1,5,0)
 ;;=5^Anemia Nos
 ;;^UTILITY(U,$J,358.3,19591,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,19592,0)
 ;;=279.8^^129^1109^4
 ;;^UTILITY(U,$J,358.3,19592,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19592,1,4,0)
 ;;=4^279.8
 ;;^UTILITY(U,$J,358.3,19592,1,5,0)
 ;;=5^Immune Mechanism Dis Nec
 ;;^UTILITY(U,$J,358.3,19592,2)
 ;;=^267970
 ;;^UTILITY(U,$J,358.3,19593,0)
 ;;=273.2^^129^1109^5
 ;;^UTILITY(U,$J,358.3,19593,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19593,1,4,0)
 ;;=4^273.2
 ;;^UTILITY(U,$J,358.3,19593,1,5,0)
 ;;=5^Paraproteinemia / Other Vasculitis
 ;;^UTILITY(U,$J,358.3,19593,2)
 ;;=^87770
 ;;^UTILITY(U,$J,358.3,19594,0)
 ;;=275.49^^129^1109^3
 ;;^UTILITY(U,$J,358.3,19594,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19594,1,4,0)
 ;;=4^275.49
 ;;^UTILITY(U,$J,358.3,19594,1,5,0)
 ;;=5^Disorder Of Calcium Blood Levels
 ;;^UTILITY(U,$J,358.3,19594,2)
 ;;=^317904
 ;;^UTILITY(U,$J,358.3,19595,0)
 ;;=90471^^130^1111^1^^^^1
 ;;^UTILITY(U,$J,358.3,19595,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19595,1,2,0)
 ;;=2^90471
 ;;^UTILITY(U,$J,358.3,19595,1,3,0)
 ;;=3^Immunization Admin (use w/ Vaccs)
 ;;^UTILITY(U,$J,358.3,19596,0)
 ;;=90472^^130^1111^2^^^^1
 ;;^UTILITY(U,$J,358.3,19596,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19596,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,19596,1,3,0)
 ;;=3^Immunization Admin, ea add
 ;;^UTILITY(U,$J,358.3,19597,0)
 ;;=90632^^130^1111^3^^^^1
 ;;^UTILITY(U,$J,358.3,19597,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,19597,1,2,0)
 ;;=2^90632
 ;;^UTILITY(U,$J,358.3,19597,1,3,0)
 ;;=3^Hepatitis A Vaccine
